Residual Viraemia in HIV‐1‐Infected Patients with Plasma Viral Load ≤20 copies/ml is Associated with Increased Blood Levels of Soluble Immune Activation Markers

Keywords

Computer science

References

• Serum beta 2-microglobulin and C reactive protein concentrations in viral infections.A.A. Neifakh, N. N. Rott — 1984
• HIV-1 Viral Replication below 50 Copies/ml in Patients on Antiretroviral Therapy is not associated with CD8+ T-cell ActivationAlan Steel, Alison Cox, Mohamed H. Shamji — 2007
• Statistical analysis of repeated measures data using SAS procedures.Ramon C. Littell, P. R. Henry, C. B. Ammerman — 1998
• HIV treatment response and prognosis in Europe and North America in the first decade of highly active antiretroviral therapy: a collaborative analysis.Margaret May, Jonathan A C Sterne, Dominique Costagliola — 2006
• Lethal T cell immunodeficiency induced by chronic costimulation via CD27-CD70 interactionsKiki Tesselaar, Ramon Arens, Gijs M.W. van Schijndel — 2003
• Investigating Signs of Recent Evolution in the Pool of Proviral HIV Type 1 DNA during Years of Successful HAARTHelene Mens, Anders Gorm Pedersen, Louise B. Jørgensen — 2007
• Immunologic and virologic evolution during periods of intermittent and persistent low-level viremiaAnnika C. Karlsson, Sophie R. Younger, Jeffrey N. Martin — 2004
• Productive Infection Maintains a Dynamic Steady State of Residual Viremia in Human Immunodeficiency Virus Type 1-Infected Persons Treated with Suppressive Antiretroviral Therapy for Five YearsDiane V. Havlir, Matthew C. Strain, Mario Clerici — 2003
• CD4+ T-cell depletion in HIV infection: Are we closer to understanding the cause?Zvi Grossman, Martin Meier‐Schellersheim, Ana E. Sousa — 2002
• 2B4 expression on natural killer cells increases in HIV‐1 infected patients followed prospectively during highly active antiretroviral therapySisse Rye Ostrowski, Henrik Ullum, Bente Klarlund Pedersen — 2005
• Intensification of Antiretroviral Therapy Accelerates the Decay of the HIV-1 Latent Reservoir and Decreases, But Does Not Eliminate, Ongoing Virus ReplicationBharat Ramratnam, Ruy M. Ribeiro, He Tian — 2004
• Low-level viremia persists for at least 7 years in patients on suppressive antiretroviral therapySarah Palmer, Frank Maldarelli, Ann Wiegand — 2008
• Changes in hospital admissions across Europe: 1995–2003. Results from the EuroSIDA studyAmanda Mocroft, Antonella d’Arminio Monforte, Ole Kirk — 2004
• The potential biological and clinical significance of the soluble tumor necrosis factor receptors.Dan Aderka — 1996
• Continued CD4 cell count increases in HIV-infected adults experiencing 4 years of viral suppression on antiretroviral therapyPeter W. Hunt, Steven G. Deeks, Benigno Rodríguez — 2003
• The multifactorial nature of HIV-1 latency.Kara G. Lassen, Yefei Han, Yan Zhou — 2004
• The CD28/HLA‐DR expressions on CD4+T but not CD8+T cells are significant predictors for progression to AIDSB. Y. Choi, Y.-K. Park, JS Lee — 2002
• Soluble Urokinase Receptor Levels in Plasma During 5 Years of Highly Active Antiretroviral Therapy in HIV-1–Infected PatientsSisse Rye Ostrowski, Terese L. Katzenstein, Timo Piironen — 2004
• Virological and immunological profiles among patients with undetectable viral load followed prospectively for 24 monthsTerese L. Katzenstein, Henrik Ullum, BT Røge — 2003
• Comparison of two automated nucleic acid testing systems for simultaneous detection of human immunodeficiency virus and hepatitis C virus RNA and hepatitis B virus DNAAngelo R. Margaritis, Stewart M. Brown, Clive R. Seed — 2007

Cited by

• Impact de différents traitements antirétroviraux (ARV) sur l'évolution des marqueurs d'inflammation et d'activation immunitaire plasmatiques chez les patients infectés par le VIHSuhaib Hattab — 2014
• Interleukin-37 Expression Is Increased in Chronic HIV-1-Infected Individuals and Is Associated with Inflammation and the Size of the Total Viral ReservoirJesper Falkesgaard Højen, Thomas A. Rasmussen, Karen Lise Dahl Andersen — 2015
• HEFFICON: HIV Effectiveness Italian Conference.Andrea Antinori, Massimo Andreoni, Carlo Federico Perno — 2015
• T Cell Subsets in HIV Infected Patients after Successful Combination Antiretroviral Therapy: Impact on Survival after 12 YearsFrederikke F. Rönsholt, Sisse Rye Ostrowski, Terese L. Katzenstein — 2012
• Modification of the Abbott RealTime assay for detection of HIV-1 plasma RNA viral loads less than one copy per milliliterSteven A. Yukl, Peilin Li, Katsuya Fujimoto — 2011
• Beyond Virological Suppression: The Role of Adherence in the Late Haart EraAdriana Ammassari, Maria Paola Trotta, Noga Shalev — 2012
• Effects of human immunodeficiency virus on the erythrocyte and megakaryocyte lineages.Davide Gibellini — 2013
• HIV-1 Residual Viremia Correlates with Persistent T-Cell Activation in Poor Immunological Responders to Combination Antiretroviral TherapyMaud Mavigner, Pierre Delobel, Michelle Cazabat — 2009
• Significance and Clinical Management of Persistent Low-Level Viremia and Very-Low-Level Viremia in HIV-1-Infected PatientsPatrick Ryscavage, Sean G. Kelly, Jonathan Z. Li — 2014
• HIV-Infected Adolescent, Young Adult and Pregnant Smokers: Important Targets for Effective Tobacco Control ProgramsGerome Escota, Nur F. Önen — 2013
• Vitamin D and calcium abnormalities in the HIV-infected population.Gerome Escota, Sara Cross, William G. Powderly — 2014
• Effect of combination antiretroviral treatment on total protein and calculated globulin levels among HIV-infected patients.José A. Serpa, Danish Haque, Josemon Valayam — 2010
• Impact of antiretroviral therapy (ART) timing on chronic immune activation/inflammation and end-organ damageReena Rajasuriar, Edwina Wright, Sharon R. Lewin — 2015
• Vitamin D Deficiency in HIV Infection: Not Only a Bone DisorderPasquale Mansueto, Aurelio Seidita, Giustina Vitale — 2015
• Lack of correlation between the size of HIV proviral DNA reservoir and the level of immune activation in HIV-infected patients with a sustained undetectable HIV viral load for 10 years.Isabelle Poizot‐Martin, Olivia Zaegel‐Faucher, Veronique Obry‐Roguet — 2013
• HIV-related mechanisms in atherosclerosis and cardiovascular diseasesDavide Gibellini, Marco Borderi, Alberto Clô — 2013
• The macrophage: the intersection between HIV infection and atherosclerosisSuzanne M. Crowe, Clare L V Westhorpe, Nigora Mukhamedova — 2010
• Persistent immune activation in chronic HIV infection: do any interventions work?Reena Rajasuriar, Gabriela Khoury, Adeeba Kamarulzaman — 2013
• Association between Latent Proviral Characteristics and Immune Activation in Antiretrovirus-Treated Human Immunodeficiency Virus Type 1-Infected AdultsEmily C. Liang, Lindsay A. Sceats, Nicholas Bayless — 2014
• Cardiovascular disease in HIV patients: from bench to bedside and backwardsEnrico Cerrato, Andrea Calcagno, Fabrizio D’Ascenzo — 2015

Related papers

No related papers recorded.